American Biotech Billionaire’s BeiGene Achieves Listing Milestone But Drops 16% In Shanghai Debut

Shares dropped more than 16% from their IPO price amid worries about possible U.S. delisting of Chinese businesses. BeiGene, led by American billionaire entrepreneur John Oyler, raised the equivalent …
( read original story …)

---